Western blotting analysis of tumor tissues (Figure 6g,h) found that EVO remarkably reduced the expression levels of proteins β-catenin, c-MYC, Cyclin D1, and ASS1 in subcutaneous CRC syngeneic tumor allografts. Here, ASS1 is linked to colorectal carcinoma.